Skip to main content
. Author manuscript; available in PMC: 2013 Jun 15.
Published in final edited form as: Cancer. 2012 Feb 27;118(12):3116–3122. doi: 10.1002/cncr.26568

Table 2.

Prognostic Factors Associated with Survival

Survival
Parameter Category n %7-yr %10-yr Univariate p value Hazard ratio Multivariate p value
Age (years) <60 247 82 75 <0.001 2.2 <0.001
> = 60 121 66 55
CML duration (months) <12 36 73 69 0.18 NS
12-35 163 80 74
>=36 169 74 62
Splenomegaly No 314 80 73 <0.001 NS
Yes 52 50 34
Hemoglobin (g/dL) <10 26 52 41 0.001 2.53 N.S. 0.003 N.S.
10-11.9 123 77 68
>=12 219 79 72
Platelet (×109/L) <=450 296 80 71 0.001 NS
>450 72 64 55
WBC (×109/L) <10 197 83 77 <0.001 NS
10-50 133 73 60
>50 38 53 49
%PB blasts 0 301 82 74 <0.001 2.45 <0.001
>=1 67 50 42
%M blasts <5 335 78 69 0.03 NS
>=5 33 61 56
%PB baso <7 332 78 69 0.11 NS
>=7 36 61 56
%M baso <5 324 80 73 <0.001 1.79 0.02
>=5 44 48 33
CE No 301 79 71 0.006 1.63 0.04
Yes 66 64 56
% Ph+mets <=90 111 89 79 0.002 NS
>90 256 71 64
IFN failure Hematologic 47 59 56 <0.001 NS
Cytogenetic 171 83 77
intolerance 148 74 62

PB =peripheral blood; M=marrow; baso = basophils; CE=clonal evolution; Ph+mets = Philadelphia + metaphases; IFN = interferon alpha;